Loading...
•
Jun 30, 2022
Acadia Healthcare Q2 2022 Earnings Report
Acadia Healthcare reported strong financial results driven by increased revenue and strategic growth initiatives.
Key Takeaways
Acadia Healthcare reported an 11.9% increase in revenue, reaching $651.7 million. Net income attributable to Acadia totaled $80.1 million, or $0.88 per diluted share. The company raised its financial guidance for 2022, reflecting confidence in continued growth.
Revenue totaled $651.7 million, an increase of 11.9% over the second quarter of 2021.
Same facility revenue increased 8.5% compared to the second quarter of 2021.
Net income attributable to Acadia totaled $80.1 million, or $0.88 per diluted share.
The company added 78 beds to existing facilities during the first half of the year and is on track to add approximately 300 beds in 2022.
Forward Guidance
Acadia raised its previously announced financial guidance for 2022.
Positive Outlook
- Revenue $2.56 to $2.60 billion
- Adjusted EBITDA, including income from PRF $591.5 to $621.5 million
- Adjusted EBITDA, excluding income from PRF $583 to $613 million
- Adjusted earnings per diluted share, including income from PRF $3.00 to $3.25
- Adjusted earnings per diluted share, excluding income from PRF $2.93 to $3.18
Challenges Ahead
- Interest Expense $67 to $70 million
- Tax rate 25% to 26%
- Depreciation and amortization expense $120 to $125 million
- Stock compensation expense Approximately $30 million
- The Company’s guidance does not include the impact of any future acquisitions, divestitures or transaction-related expenses.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...